+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Crispr Genomic Cure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Crispr Genomic Cure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Crispr Genomic Cure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • February 2025
  • Region: Global
  • TechSci Research
  • ID: 5908253
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Crispr Genomic Cure Market was valued at USD 2.95 Billion in 2024, and is expected to reach USD 11.36 Billion by 2030, rising at a CAGR of 25.15%. The global CRISPR genomic cure market is a rapidly evolving sector within the biotechnology and healthcare industries. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized gene editing and holds immense promise for treating various genetic and hereditary diseases.

Key Market Drivers

Increasing Prevalence of Genetic Disorders and Chronic Diseases

The growing incidence of genetic disorders and chronic diseases is a major driver behind the rapid expansion of the Global CRISPR Genomic Cure Market. Genetic disorders and congenital abnormalities affect approximately 2%-5% of all live births, contributing to up to 30% of pediatric hospital admissions and accounting for nearly 50% of childhood mortality in industrialized nations. These figures highlight a critical demand for advanced genomic interventions, positioning CRISPR-based therapies as a transformative solution in pediatric healthcare.

As the burden of hereditary and chronic illnesses continues to rise worldwide, there is an increasing demand for innovative, targeted, and long-term solutions to treat these conditions. CRISPR-based gene editing has emerged as a groundbreaking approach, offering precise and potentially curative treatments for diseases with a strong genetic basis. The incidence of genetic disorders and chronic diseases is increasing due to factors such as aging populations, environmental influences, and inherited genetic mutations. Annually,

Key Market Challenges

Ethical and Regulatory Hurdles

Perhaps one of the most significant challenges is the ethical and regulatory landscape surrounding CRISPR technology. The ethical debate over gene editing in humans, particularly germline editing, remains a contentious issue. Regulatory agencies worldwide are grappling with the need to strike a balance between fostering innovation and ensuring safety and ethical considerations.

Key Market Players

  • Merck KGaA
  • Takara Bio Inc
  • Lonza Group AG
  • Horizon Discovery Group Ltd
  • Genscript Biotech Corp
  • Synthego Corp
  • Precision BioSciences Inc
  • Mammoth Biosciences Inc
  • Thermo Fisher Scientific Inc
  • Intellia Therapeutics Inc

Report Scope:

In this report, the Global Crispr Genomic Cure Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Crispr Genomic Cure Market, By Disease Type:

  • Genetic Disorders
  • Cancer
  • Infectious Diseases
  • Neurological Disorders
  • Cardiovascular Disorders
  • Blood Disorders
  • Metabolic Disorders
  • Others

Crispr Genomic Cure Market, By Therapy Type:

  • Gene Editing
  • Gene Therapy
  • Cell Therapy
  • Immunotherapy

Crispr Genomic Cure Market, By Delivery Method:

  • In vivo
  • Ex vivo

Crispr Genomic Cure Market, By End User:

  • Hospitals & Clinics
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies

Crispr Genomic Cure Market, By Targeted Genetic Modification:

  • Single Gene Modification
  • Multiple Gene Modification
  • Genome-wide Modification

Crispr Genomic Cure Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Crispr Genomic Cure Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Crispr Genomic Cure Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Disease Type (Genetic Disorders, Cancer, Infectious Diseases, Neurological Disorders, Cardiovascular Disorders, Blood Disorders, Metabolic Disorders, Others)
5.2.2. By Therapy Type (Gene Editing, Gene Therapy, Cell Therapy, Immunotherapy)
5.2.3. By Delivery Method (In vivo, Ex vivo)
5.2.4. By End User (Hospitals & Clinics, Research Institutes, Biotechnology & Pharmaceutical Companies)
5.2.5. By Targeted Genetic Modification (Single Gene Modification, Multiple Gene Modification, Genome-wide Modification)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Crispr Genomic Cure Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type
6.2.2. By Therapy Type
6.2.3. By Delivery Method
6.2.4. By End User
6.2.5. By Targeted Genetic Modification
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Crispr Genomic Cure Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Disease Type
6.3.1.2.2. By Therapy Type
6.3.1.2.3. By Delivery Method
6.3.1.2.4. By End User
6.3.1.2.5. By Targeted Genetic Modification
6.3.2. Canada Crispr Genomic Cure Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Disease Type
6.3.2.2.2. By Therapy Type
6.3.2.2.3. By Delivery Method
6.3.2.2.4. By End User
6.3.2.2.5. By Targeted Genetic Modification
6.3.3. Mexico Crispr Genomic Cure Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Disease Type
6.3.3.2.2. By Therapy Type
6.3.3.2.3. By Delivery Method
6.3.3.2.4. By End User
6.3.3.2.5. By Targeted Genetic Modification
7. Europe Crispr Genomic Cure Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Type
7.2.2. By Therapy Type
7.2.3. By Delivery Method
7.2.4. By End User
7.2.5. By Targeted Genetic Modification
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Crispr Genomic Cure Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Type
7.3.1.2.2. By Therapy Type
7.3.1.2.3. By Delivery Method
7.3.1.2.4. By End User
7.3.1.2.5. By Targeted Genetic Modification
7.3.2. United Kingdom Crispr Genomic Cure Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Type
7.3.2.2.2. By Therapy Type
7.3.2.2.3. By Delivery Method
7.3.2.2.4. By End User
7.3.2.2.5. By Targeted Genetic Modification
7.3.3. Italy Crispr Genomic Cure Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Disease Type
7.3.3.2.2. By Therapy Type
7.3.3.2.3. By Delivery Method
7.3.3.2.4. By End User
7.3.3.2.5. By Targeted Genetic Modification
7.3.4. France Crispr Genomic Cure Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Type
7.3.4.2.2. By Therapy Type
7.3.4.2.3. By Delivery Method
7.3.4.2.4. By End User
7.3.4.2.5. By Targeted Genetic Modification
7.3.5. Spain Crispr Genomic Cure Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Type
7.3.5.2.2. By Therapy Type
7.3.5.2.3. By Delivery Method
7.3.5.2.4. By End User
7.3.5.2.5. By Targeted Genetic Modification
8. Asia-Pacific Crispr Genomic Cure Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By Therapy Type
8.2.3. By Delivery Method
8.2.4. By End User
8.2.5. By Targeted Genetic Modification
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Crispr Genomic Cure Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Type
8.3.1.2.2. By Therapy Type
8.3.1.2.3. By Delivery Method
8.3.1.2.4. By End User
8.3.1.2.5. By Targeted Genetic Modification
8.3.2. India Crispr Genomic Cure Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Type
8.3.2.2.2. By Therapy Type
8.3.2.2.3. By Delivery Method
8.3.2.2.4. By End User
8.3.2.2.5. By Targeted Genetic Modification
8.3.3. Japan Crispr Genomic Cure Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Type
8.3.3.2.2. By Therapy Type
8.3.3.2.3. By Delivery Method
8.3.3.2.4. By End User
8.3.3.2.5. By Targeted Genetic Modification
8.3.4. South Korea Crispr Genomic Cure Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Type
8.3.4.2.2. By Therapy Type
8.3.4.2.3. By Delivery Method
8.3.4.2.4. By End User
8.3.4.2.5. By Targeted Genetic Modification
8.3.5. Australia Crispr Genomic Cure Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Type
8.3.5.2.2. By Therapy Type
8.3.5.2.3. By Delivery Method
8.3.5.2.4. By End User
8.3.5.2.5. By Targeted Genetic Modification
9. South America Crispr Genomic Cure Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Type
9.2.2. By Therapy Type
9.2.3. By Delivery Method
9.2.4. By End User
9.2.5. By Targeted Genetic Modification
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Crispr Genomic Cure Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Type
9.3.1.2.2. By Therapy Type
9.3.1.2.3. By Delivery Method
9.3.1.2.4. By End User
9.3.1.2.5. By Targeted Genetic Modification
9.3.2. Argentina Crispr Genomic Cure Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Type
9.3.2.2.2. By Therapy Type
9.3.2.2.3. By Delivery Method
9.3.2.2.4. By End User
9.3.2.2.5. By Targeted Genetic Modification
9.3.3. Colombia Crispr Genomic Cure Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Type
9.3.3.2.2. By Therapy Type
9.3.3.2.3. By Delivery Method
9.3.3.2.4. By End User
9.3.3.2.5. By Targeted Genetic Modification
10. Middle East and Africa Crispr Genomic Cure Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By Therapy Type
10.2.3. By Delivery Method
10.2.4. By End User
10.2.5. By Targeted Genetic Modification
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Crispr Genomic Cure Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Type
10.3.1.2.2. By Therapy Type
10.3.1.2.3. By Delivery Method
10.3.1.2.4. By End User
10.3.1.2.5. By Targeted Genetic Modification
10.3.2. Saudi Arabia Crispr Genomic Cure Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Type
10.3.2.2.2. By Therapy Type
10.3.2.2.3. By Delivery Method
10.3.2.2.4. By End User
10.3.2.2.5. By Targeted Genetic Modification
10.3.3. UAE Crispr Genomic Cure Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Type
10.3.3.2.2. By Therapy Type
10.3.3.2.3. By Delivery Method
10.3.3.2.4. By End User
10.3.3.2.5. By Targeted Genetic Modification
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Crispr Genomic Cure Market: SWOT Analysis
14. Competitive Landscape
14.1. Merck KGaA
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Takara Bio Inc
14.3. Lonza Group AG
14.4. Horizon Discovery Group Ltd
14.5. Genscript Biotech Corp
14.6. Synthego Corp
14.7. Precision BioSciences Inc
14.8. Mammoth Biosciences Inc
14.9. Thermo Fisher Scientific Inc
14.10. Intellia Therapeutics Inc.
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Merck KGaA
  • Takara Bio Inc
  • Lonza Group AG
  • Horizon Discovery Group Ltd
  • Genscript Biotech Corp
  • Synthego Corp
  • Precision BioSciences Inc
  • Mammoth Biosciences Inc
  • Thermo Fisher Scientific Inc
  • Intellia Therapeutics Inc

Table Information

Report AttributeDetails
No. of Pages180
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.36 Billion
Compound Annual Growth Rate25.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029 - Product Image

Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029

  • Report
  • 180 Pages
  • Global
From
Global CRISPR Gene Editing Market Report 2024 - Product Image

Global CRISPR Gene Editing Market Report 2024

  • Report
  • 175 Pages
  • Global
From
CRISPR Technology - Global Strategic Business Report - Product Image

CRISPR Technology - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
CRISPR and Cas Gene Global Market Report 2024 - Product Image

CRISPR and Cas Gene Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
CRISPR and Cas Genes Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

CRISPR and Cas Genes Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.